DaVita (DVA): analysis and statistics
Return, volatility, Sharpe ratio and risk for DaVita, a component of the S&P 500 in the Health Care. Data as of 2026-10-29.
| Last close price | $183.93 |
| Sector (GICS) | Health Care |
| Annualized return (3.0 yr) | +34.02% |
| Total return over period | +139.59% |
| Annualized volatility | 36.53% |
| Period volatility | 63.10% |
| Period T-bill | 12.40% |
| Sharpe ratio | 2.02 |
| Sortino ratio | 3.13 |
| Max drawdown | -41.43% |
| CVaR 95% (avg. loss, worst 5% of days) | -4.78% |
| Correlation with the S&P 500 | 0.15 |
| Period range | $76.64 – $240.96 |
| Trading days analyzed | 752 |
Over the last 3.0 years, DaVita (DVA) has posted an annualized return of +34.02% with annual volatility of 36.53%, a Sharpe ratio of 2.02. Its worst stretch (max drawdown from a peak) was -41.43%. Its correlation with the S&P 500 is 0.15, which means it moves fairly independently of the index, useful for diversification.
These are historical, realized metrics, not projections: they describe how the stock behaved, not how it will behave going forward. To see how DVA would fit inside an optimized portfolio alongside other stocks, try the optimizer.
Optimize a portfolio with DVA →
Other Health Care stocks
Is it part of the S&P 500?
Yes, DaVita (DVA) is of the S&P 500.
What is the Sharpe ratio? · How to optimize an investment portfolio